Prostate Cancer - Results from #20

PIRADS 3 MRI lesions: are biopsies still necessary? January 7, 2025

Selective treatment de-escalation in advanced prostate cancer: have we come full circle? January 6, 2025

Incidence and Survival of Patients With Prostate Cancer in North-Rhine Westphalia, Germany. January 6, 2025

Structurally-oriented classification of FOXA1 alterations identifies prostate cancers with opposing clinical outcomes and distinct molecular and immunologic subtypes. January 6, 2025

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer. January 6, 2025

Alternate definitions of adverse pathology to predict a very high risk of metastasis in men with intermediate- and low-risk prostate cancer. January 6, 2025

MRI-based Radiomics for Predicting Prostate Cancer Grade Groups: A Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies. January 3, 2025

Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow-up analysis of the COVIDSurg-Cancer study. January 3, 2025

Prospective per-target analysis of the added value of the PrecisionPoint Transperineal Access System in cognitive prostate biopsy of MRI targets. January 3, 2025

Targeted microwave ablation of localised prostate cancer: Initial results of VIOLETTE trial. January 3, 2025

Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis-a systematic review including meta-analysis of all comparative studies. January 3, 2025

Challenges of Urologic Oncology in Low-to-Middle-Income Countries January 2, 2025

Urologic Cancer Drug Costs in Low- and Middle-Income Countries January 2, 2025

Life expectancy in rare histological prostate cancer subtypes. January 2, 2025

Prostate cancer MRI methodological radiomics score: a EuSoMII radiomics auditing group initiative. January 2, 2025

The PROCAN-B study protocol: Early diagnosis of PROstate CANcer for Black men-a community-centred participatory approach in Scotland and the North-East of England. January 2, 2025

The 340B Drug Pricing Program and Management of Advanced Prostate Cancer. January 2, 2025

Functional outcomes of single-session holmium laser enucleation of the prostate and high-intensity focused ultrasound in management of patients with prostate cancer and enlarged prostate: results from a pilot study. January 2, 2025

PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial. January 1, 2025

Prostate-specific antigen testing in the United States during 2008-2022 in relation to the US preventive services task force recommendations. January 1, 2025

Page 2 of 1451